HIGHLIGHTS:

  • 75% of the US vaccine doses would be shared via COVAX program
  • US said that 25% of the supplies will cater to immediate needs of the Covid-19 infected areas around the world
  • The plan of first 25 million doses has been drafted and by the end of June 2021 at least 80 million doses of vaccine will be supplied by US
  • 19 million would be shared with COVAX while remaining 6 million doses will be supplied to Central and South American countries
  • India would be benefited after restrictions on export of raw materials under the Defense Production Act for the AstraZeneca and the Novovax shots are relieved

On Thursday, the US government declared that it has planned to share 80 million doses of Covid-19 vaccine supply in order to lead the fight against the disease globally. The plan of the first 25 million doses has been drafted and by the end of June 2021 at least 80 million doses of vaccine will be supplied by the US.

The US statement stated that 75% of the US vaccine doses would be shared via the COVAX program. It added that the US prioritized Latin America and Caribbean, South and Southeast Asia and Africa in coordination with the African Union. The US said that 25% of the supplies will cater to immediate needs of the Covid-19 infected areas around the world.

Out of the first 25 million doses, 19 million would be shared with COVAX while remaining 6 million doses will be supplied to Central and South American countries.

Approximately 7 million doses will be received by India, Nepal, Bangladesh, Pakistan, Sri Lanka, Afghanistan, Maldives, Malaysia, Philippines, Vietnam, Indonesia, Thailand, Laos, Papua New Guinea, Taiwan, and the Pacific Islands. African Union has selected some African countries who will be allotted 5 million doses.

Mexico, Canada, and the Republic of Korea, West Bank and Gaza, Ukraine, Kosovo, Haiti, Georgia, Egypt, Jordan, Iraq, and Yemen and UN frontline workers will be receiving 6 million doses that have been allotted for regional priorities and partner to partner recipients.

Johnson & Johnson, Pfizer and Moderna shots will be supplied in the first 25 million doses while the Food and Drug Administration is yet to permit the 60 million AstraZeneca shots that President Joe Biden had earlier promised to share.

LEAVE A REPLY

Please enter your comment!
Please enter your name here